Back to
Ameriprise Financial Inc.
AUPH
Showing 8 of 14 quarters
Position history for
Ameriprise Financial Inc.'s holdings in Aurinia Pharmaceuticals Inc
Yes. Ameriprise Financial holds 11,053 shares of AUPH (Aurinia Pharmaceuticals), worth $187,570, as of its Q2 2026 13F filing. It reduced the position by 33,395 shares (-75.1%) from Q1 2026. Ameriprise Financial has held AUPH since Q2 2024, across 9 quarterly 13F filings.
Current Value
$187,570
Current Shares
11,053
Total Value Change
+$108,296
Total Shares Change
+238
Quarter-by-Quarter History